Blackstone Life Sciences and Anthos Therapeutics Announce …
1 day ago · Anthos was founded by Blackstone Life Sciences and Novartis in 2019 with the exclusive global rights from Novartis to develop, manufacture, and commercialize abelacimab, …
Novartis bolsters late-stage cardiovascular pipeline with …
23 hours ago · Anthos Therapeutics, launched by Blackstone Life Sciences and Novartis in 2019, has advanced abelacimab through clinical development under a license from Novartis. …
Novartis agrees to acquire Anthos for up to $3.1 billion | Reuters
1 day ago · Anthos was founded by Blackstone Life Sciences and Novartis in 2019 to develop, manufacture, and commercialize abelacimab, a treatment to prevent stroke and the recurrence …
Blackstone Life Sciences and Anthos Therapeutics ... - Business Wire
1 day ago · Anthos was founded by Blackstone Life Sciences and Novartis in 2019 with the exclusive global rights from Novartis to develop, manufacture, and commercialize abelacimab, …
Novartis signs agreement to acquire Anthos for $925m upfront
20 hours ago · Novartis has agreed to acquire Boston-based clinical-stage biopharmaceutical company Anthos Therapeutics for an upfront payment of $925m. The transaction includes …
Blackstone Life Sciences and Anthos Therapeutics Announce
1 day ago · Founded by Blackstone Life Sciences (BXLS) in 2019, Anthos Therapeutics is a transformative, clinical-stage biopharmaceutical company with the exclusive global rights from …
Novartis inks $925M Anthos takeover to rejoin clot-busting race
20 hours ago · Novartis has brought abelacimab back into the fold. Six years after spinning the asset out to form Anthos Therapeutics, Novartis has struck a deal to buy Anthos for $925 …
Novartis agrees $3bn deal to buy heart drug biotech from …
20 hours ago · Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed the drug abelacimab from Novartis in 2019, providing $250mn for clinical trials involving patients at …
Novartis to Buy Anthos Therapeutics for $925 Million
1 day ago · Novartis AG has agreed to acquire Anthos Therapeutics for $925 million as the European drug giant seeks to bolster its late-stage cardiovascular pipeline.. Under the …
Blackstone Life Sciences and Novartis Launch Anthos …
Feb 27, 2019 · Cambridge, Massachusetts, February 27, 2019 – Blackstone Life Sciences today announced the launch of Anthos Therapeutics Inc. (“Anthos”), a new biopharmaceutical …
- Some results have been removed